Vaccine, mumps

Generic Medicine Info
Indications and Dosage
Active immunisation against mumps
Adult: 0.5 mL as a single dose via SC admin, preferably into the outer aspect of the upper arm.
Child: Given as a combination with measles and rubella vaccines: ≥12 mth: 2 doses of 0.5 ml via IM admin (SC admin if there is bleeding disorder). 1st dose is usually given after 1st birthday (recommended age: 12-15 mth) and 2nd dose at 3-5 yr or prior to school entry. Doses should be separated by at least 4 wk. May be given at any age if routine admin has been omitted. Immunisation dose given before 12 mth of age may not be effective long term and patients should be revaccinated with the 2 dose schedule.
Pregnancy. Hypersensitivity. Severe primary immunodeficiency; current treatment with chemotherapy or radiotherapy and within 6 mth of stopping such therapy; solid organ transplant patients receiving immunosuppressants, bone marrow transplant and for at least 12 mth after stopping immunosuppressive therapy, patients on high-dose systemic corticosteroids, HIV patients with immunosuppression.
Special Precautions
Women of child-bearing age should be vaccinated if they are seronegative; those who are found to be seronegative during pregnancy should be vaccinated in the early postpartum period. Not advisable to become pregnant within 1 mth of vaccination. Not recommended for children <1 yr. Allow alcohol or disinfectant that is used for skin cleansing to evaporate before vaccination to prevent inactivation of live vaccines. Bleeding disorders (use SC route).
Adverse Reactions
Skin rashes, pharyngitis, fever, and lymphadenopathy; arthralgia and arthritis may occur.
Parenteral/SC: C (FDA Pregnancy Category C applies in combination w/ measles & rubella vaccines.)
Drug Interactions
Not to be given within 1 mth of admin of other live vaccines. Live vaccines should only be given at least 3 wk before or 3 mth after the use of immunoglobulin. Avoid admin during immunosuppressant or high dose systemic corticosteroid therapy.
Description: The mumps vaccine is a preparation of live, attenuated organisms of the Jeryl Lynn (B level) strain of the virus.
Store at 2-8°C. After reconstitution, discard if not used within 8 hr.
Disclaimer: This information is independently developed by MIMS based on Vaccine, mumps from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in